MacAndrews & Forbes

vTv Therapeutics LLC is a clinical-stage biopharmaceutical company dedicated to the discovery and development of orally administered small molecule therapeutics aimed at addressing unmet medical needs across a variety of human diseases. The company has a diverse pipeline that includes drug candidates targeting central nervous system disorders, diabetes, inflammation, and cancer, with a primary focus on Alzheimer's disease and Type 2 diabetes. Notable candidates in development include Azeliragon, which is in Phase II clinical trials for mild Alzheimer's disease, and TTP399, a liver-selective glucokinase activator that has completed Phase II trials for Type 2 diabetes. vTv Therapeutics is also advancing additional compounds such as TTP273 and HPP737, among others, to tackle chronic diseases. Founded in 1998 and based in High Point, North Carolina, vTv Therapeutics operates as a subsidiary of vTv Therapeutics Inc. and emphasizes a commitment to innovative drug discovery through its in-house research and strategic collaborations.

Relationship Science LLC is a technology solutions company that provides a web-based platform designed to enhance business relationships for various sectors, including investment banking, private equity, and corporate services. Founded in 2010 and based in New York, the company offers clients access to comprehensive information about over 6 million influential decision-makers, facilitating connections that can lead to new partnerships, client acquisitions, and market entry. The platform also features tools for relationship mapping, enabling users to identify commonalities and leverage existing connections to gain insights and opportunities. By integrating actionable intelligence and analytics, Relationship Science empowers organizations to turn professional relationships into a competitive advantage. The company, previously known as Connectivity Data Systems LLC, rebranded in September 2012 to reflect its focus on relationship-driven business development.

Relationship Science LLC is a technology solutions company that provides a web-based platform designed to enhance business relationships for various sectors, including investment banking, private equity, and corporate services. Founded in 2010 and based in New York, the company offers clients access to comprehensive information about over 6 million influential decision-makers, facilitating connections that can lead to new partnerships, client acquisitions, and market entry. The platform also features tools for relationship mapping, enabling users to identify commonalities and leverage existing connections to gain insights and opportunities. By integrating actionable intelligence and analytics, Relationship Science empowers organizations to turn professional relationships into a competitive advantage. The company, previously known as Connectivity Data Systems LLC, rebranded in September 2012 to reflect its focus on relationship-driven business development.

Transactis, Inc. is a New York-based company specializing in Software-as-a-Service solutions for electronic bill presentment and payment. Established in 2001, Transactis enables businesses to transition from traditional paper-based billing to efficient digital alternatives. Its primary offerings include BillerIQ, a cloud platform for delivering electronic bills and accepting online, phone, and mobile payments, and DocumentIQ, a digital document management system for transforming and archiving documents. The company serves a diverse array of industries, including financial services, healthcare, utilities, and retail, among others. Operating solely through a network of resellers, which include financial institutions and technology companies, Transactis provides white-label SaaS solutions along with substantial sales, marketing, and technical support to empower its partners. The company adheres to rigorous regulatory standards, ensuring compliance with regulations such as HIPAA and PCI Level 1.

CircuLite is a cardiovascular device company focused on transforming the treatment of heart failure through the development of minimally-invasive micro-pumps designed for long-term partial circulatory support. Its proprietary micro-pump platform allows for the creation of compact devices that can be implanted in a superficial pocket, similar to a pacemaker, utilizing endovascular or minimally-invasive surgical techniques. By supplementing a patient's natural heart function, CircuLite aims to provide a proactive and lower-risk treatment option, thereby enhancing the quality of life for millions of individuals suffering from chronic heart failure. The company’s flagship product, the Synergy Pocket Circulatory Assist Device, is designed to rest a failing heart while supporting its natural pumping capacity.

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company based in New York, specializing in health security and infectious disease markets. Established in 1995, the company develops antiviral drugs targeting lethal pathogens, including variola virus, which causes smallpox. Its primary product, TPOXX, is an orally administered antiviral treatment specifically designed for human smallpox disease. SIGA is dedicated to creating modern biodefense countermeasures against high-priority viral threats, aiming to prevent and treat diseases such as Ebola, dengue, and Lassa fever. The company primarily generates revenue from the United States market.

Vericast is a holding company that operates a diverse portfolio of marketing businesses. The company focuses on optimizing customer relationships through multiple channels, offering services in automotive, advertising, e-commerce, telecom, and intelligent media. Its key business units, including Harland Clarke, Scantron, and Valassis, provide a range of solutions, including marketing services, transaction services, education services, and intelligent media delivery. These services are designed to enhance customer engagement and create meaningful touchpoints for clients across various industries.

TransTech Pharma, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of human therapeutics. The company engages in translating human proteins into medicines for the treatment of various human diseases. Its products include a pipeline of molecule clinical and pre-clinical drug candidates, including antagonists, fusion proteins, activators, inhibitors, agonists, smallpox anti-virals, and thrombosis for the treatment of cardiovascular disorders, central nervous system disorders, inflammatory and infectious diseases, diabetes, obesity, and cancer. TransTech Pharma, Inc. has strategic alliances with Novo Nordisk A/S, Pfizer, Boehringer Ingelheim, Merck, Siga Technologies, and Cephalon. The company was founded in 1998 and is based in High Point, North Carolina.

Viaken Systems is the premier full service ASP (Application Service Provider) for the life sciences, offering solutions for biotechnology, pharmaceutical, and agricultural companies. Viaken hosts third-party research informatics application solutions and e-commerce services in the areas of genome informatics, chem informatics, and pharmaco informatics at its tier one data center and delivers these services via the Internet. The company’s unique ASP platform enables companies of all sizes to utilize the same state-of-the-art research information technology (IT) as implemented by top-tier organizations. Viaken specializes in architecture design, application and database hosting, distributed access to high performance computing services, secure network management, and 24x7x365 system and application support. The company also designs, implements, and hosts custom solutions to meet any of its customers’ IT requirements.

iHarvest is a privately funded Internet software and applications company, founded in September 1997 by Dennis Buchheim and David Wadhwani, and based in Redwood Shores, California. The company addresses the challenges faced by Internet users in managing and retaining valuable web content. Its first product, iHarvest One™, launched in July 1999, was a Microsoft Internet Explorer plug-in that allowed users to save entire web pages and organize them efficiently on their devices. This innovation led to the development of iHarvest™, a next-generation web service introduced in May 2000, which further simplified the process of saving and organizing web content. iHarvest's intuitive interface supports various applications, including financial research, job searches, and travel planning, making it suitable for both novice and experienced users. The executive team, led by Rich Buchheim, brings extensive experience from prominent technology companies, positioning iHarvest for further growth and innovation in the realm of web information management.

With the continued growth of the Internet, improved streaming technologies, and the arrival of inexpensive high-bandwidth connections to households and businesses across the United States, the market for network-centric video applications is ready to explode. This is setting the stage for video to take a bigger role online, becoming one of the driving forces in the development of the Internet. Javu Technologies has created JavuNetwork and JavuNetplay - ASP-enabling video creation and management applications, which will give business owners and consumers the opportunity to edit, enhance, and integrate the many benefits of video into their Internet experience. JavuNetwork is a Java-based, network-centric multimedia content management application that gives individuals the ability to do high-powered video, image and audio editing right from their desktops over the Internet. JavuNetplay further simplifies the online non-linear content creation process through easy-to-use templates, allowing users to build videos directly from within an internet browser. They believe there is an excellent opportunity to incorporate the JavuNetwork and JavuNetplay ASP digital media editing and management services with every ISP’s and ICP’s content offerings.

e7th is a B2B marketplace that enables its users to purchase and sell fashion and footwear products.

E-centives is a provider of online direct marketing solutions based in Bethesda, Maryland. The company specializes in offering internet coupons and digital promotions for various companies and brands. E-centives aims to facilitate more profitable relationships between merchants and consumers by leveraging digital coupon strategies. Through its services, the firm helps businesses attract and retain customers by providing effective promotional tools that enhance consumer engagement and drive sales.

Revlon, Inc. is a global company that develops, manufactures, markets, and distributes a wide range of beauty and personal care products. Founded in 1932, Revlon operates through several segments, including Revlon, Elizabeth Arden, Portfolio, and Fragrances. The Revlon segment is known for color cosmetics, beauty tools, and hair color products, while Elizabeth Arden offers skincare and fragrances. The Portfolio segment includes brands such as Almay, American Crew, and CND, which focus on cosmetics, men’s grooming, and nail care. Additionally, the Fragrances segment develops and distributes both owned and licensed fragrance brands. Revlon products are sold through various retail channels, including mass merchandisers, drugstores, and e-commerce platforms, with a significant portion of revenue generated from North America. The company's diverse brand portfolio and extensive distribution network highlight its prominent position within the cosmetics industry.